A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients.

Asbjørn Due,Tobias Berg,Maj-Britt Jensen, Sophie Yammeni, Lone Volmer,Anne Sofie Brems-Eskildsen,Klaus Kaae Andersen, Saeeda Rana,Ann Knoop,Iben Kümler

Acta oncologica (Stockholm, Sweden)（2023）

引用 0|浏览5

暂无评分

摘要

In this real-world study, we found that patients were treated with a wide variety of anti-cancer agents with modest efficacy. However, patients in this study did not have access to newer therapies like tucatinib and T-DXd.

查看译文

关键词

HER2-positive,T-DM1,breast cancer,metastatic,overall survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要